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INTRODUCTION
Neuroinflammatory diseases are clinically heterogeneous
and one of the major causes of acquired neurological disabil-
ity. An underlying complex genetic susceptibility may play
an important role in their etiologies; however, the role of
genetic factors in determining their clinical features is still
unclear. Multiple sclerosis (MS), one of the major neuroinflam-
matory diseases, recently was recognized and subsequently
well-characterized in children, but the awareness of pediatri-
cians and pediatric neurologists, especially in Asian countries
to the occurrence of MS, is still unsatisfactory. Some data pro-
vided evidences that Asian and Western type MS are distinct
regarding their immunogenetic background (1-3). Acute dis-
seminated encephalomyelitis (ADEM) is a postinfectious en-
cephalitis that is usually preceded by an infectious illness or
vaccination. The clinical manifestation has a wide spectrum
and complementary examinations are not specific, except for
magnetic resonance imaging (MRI) findings which show
multifocal white-matter lesions similar to those seen in MS
(4-9). Acute necrotizing encephalopathy (ANE), likely postin-
fectious encephalomyelitis, is not uncommon in Asian coun-
tries but is very rarely seen in Western countries. The etiol-
ogy is still unknown, but immunogenetic mechanism has
been suggested (10-15). Some data suggest that children with
postinfectious encephalomyelitis are genetically predisposed
to this demyelinating disease (16). These postinfectious en-
cephalomyelitides and multiple sclerosis have clinical, immu-
nologic, and neuroradiographic similarities. Therefore we stud-
ied HLA determinants in thirteen children consecutively diag-
nosed with neuroinflammatory disease to study the immuno-
genetic peculiarities of neuroinflammatory diseases in Korean
children.
MATERIALS AND METHODS
A total of 13 children (8 males and 5 females) with neuroin-
flammatory diseases were consecutively recruited at the sec-
tion of Pediatric Neurology, Kyungpook National University
Hospital, Daegu, Korea, between January 2000 and April
2003. The subject’s ages ranged from 1-10 yr. The studied
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Molecular Analysis of HLA Class Ⅱ-Associated Susceptibility to 
Neuroinflammatory Diseases in Korean Children
The work was done to study immunogenetic peculiarities of neuroinflammatory dis-
eases among Korean children. A total of 13 children with neuroinflammatory diseases
(8 males and 5 females; mean age 4.6±2.6 yr) were consecutively recruited. Geno-
mic typing was performed on their HLA DRB/HLA DQB genes using PCR-SSOP/
SSP techniques with gel immunoelectrophoresis. The frequencies of HLA-DR1*
15 in children with acute disseminated encephalomyelitis (ADEM) (31%) and DQB1*
06 in other neuroinflammatory diseases (38%) were significantly increased compared
with control subjects. The frequencies of HLA-DRB3*0202 (100%), HLA-DRB1*1302
(67%), HLA-DRB3*0301 (67%), and HLA-DQB1*0301 (67%) were significantly
increased in children with multiple sclerosis and the frequencies of HLA-DRB1*1501
(40%) and HLA-DRB5*0101 (40%) were significantly increased in children with
ADEM. HLA-DRB1*1401, HLA- DRB3*0202, and HLA-DQB1*0502 were found
in children with acute necrotizing encephalopathy. In conclusion, HLA-DR1*15 and
DQB1*06 may be involved in susceptibility to inflammation in Korean children. The
frequencies of HLA-DRB1*1501, HLA-DRB5*0101, HLA-DRB3*0301, and HLA-
DQB1*0602 were not as high in Korean children with multiple sclerosis as in western
children. However, HLA-DRB3*0202 was seen in all children with multiple sclerosis.
Our data may provide further evidence that the immunogenetic background of neu-
roinflammatory diseases in Korean is distinctly different from the ones in western
countries. Further studies are necessary to confirm this finding. 
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subjects included five children with ADEM, three with MS,
three with acute necrotizing encephalopathy, and two with
transverse myelitis. Three age-matched children with no neu-
rological illnesses were also evaluated as controls. 
The children with neuroinflammatory diseases and three
age-matched children with no neurological illnesses as con-
trols were molecularly typed for HLA class II genes. Genomic
DNA was prepared from peripheral blood leukocytes by using
a DNA purification kit (Promega, Madison, WI, U.S.A.)
according to standard procedures. Molecular analysis was
performed on HLA-DRB/HLA-DQB genes (chromosome
6p21) of 13 unrelated children with neuroinflammatory dis-
eases using PCR-SSOP/SSP kits (INNO-LiPA HLA-DRB,
Ghent, Belgium and Pel-Freez SSP UniTray with Taq poly-
merase, Basel, Switzerland) for low and high resolution typ-
ing, according to the manufacturer’s instructions along with
augmentation of gel immunoelectrophoresis for HLA-DQB.
Alleles were assigned according to the nomenclature for fac-
tors of the HLA system.
RESULTS
Thirteen children with neuroinflammatory diseases were
typed for HLA class II genes. Their demographic and clinical
characteristics are summarized in Table 1. Eight males and
five females were enrolled in the study. Their ages ranged from
one to ten years (mean age 4.6±2.6 yr). The three major con-
ditions were ADEM, ANE, and MS. As shown in Table 2, the
frequency of HLA-DR1*15 was significantly increased in
patients with ADEM (31%) and the frequency of DQB1*06
was also increased in other neuroinflammatory diseases (38%;
4 ADEM, 1 multiple sclerosis, 1 transverse myelitis) compared
with control subjects as well as known data of HLA-DRB
alleles in Koreans. In Korean children with multiple sclero-
sis, the frequencies of HLA-DRB1*1501, HLA-DRB5*0101,
HLA-DRB3*0301, and HLA-DQB1*0602 were not as high
as in western children, but the frequencies of HLA-DRB3*
0202 (100%), HLA-DRB1*1302 (67%), HLA-DRB3*0301
(67%), and HLA-DQB1*0301 (67%) were significantly in-
creased instead (Table 3). The frequencies of HLA-DRB1*
1501 (40%) and HLA-DRB5*0101 (40%) were significantly
increased in children with ADEM compared with control
subjects. In addition, three common alleles, HLA-DRB1*
1401, HLA-DRB3*0202, and HLA-DQB1*0502, were
found in children with acute necrotizing encephalopathy with
bilateral thalamotegmental involvement (ANEBTT) (Table 4).
DISCUSSION
In the absence of a biological marker, the distinction bet-
ween ADEM and MS cannot be made with certainty at the
time of initial manifestation and a preceding or concurrent
viral illness, high lesion load on MRI, involvement of the deep
gray matter, or absence of oligoclonal bands may be more
Sex (male:female) 8:5
Age (yr) 4.6±2.6
Family history of IND none
Clinical diagnosis
ADEM 5
CDMS/CIS 3 (2/1)
AEBTT 2
ANEBG 1
Transverse myelitis 2
Table 1. Demographic features of subjects (n=13)
IND, inflammatory neurological diseases; ADEM, acute disseminated
encephalomyelitis; CDMS/CIS, clinically definite multiple sclerosis/clini-
cally isolated syndromes suggestive of MS; AEBTT, acute encephalopa-
thy with bilateral thalamotegmental involvement; ANEBG, acute necro-
tizing encephalitis with basal ganglia involvement.
Patient Sex DRB1 DRB3 DRB5 DRB4 DQB1 Diagnosis
1 F  ANEBG 0701  1401 0202 0101 0303  0502
2  F AEBTT 1101  1401 0202  0301 0301 0502
3 M CDMS 1302  1406 0202  0301 0301 0609
4 M ADEM 1101  1502 0202 0102 03      0501
5 M AEBTT 0101  1302 0301 0501  0609
6 M TM 0405  0701 0101 0202  0401
7 M ADEM 0403  0701 0101 0202  0302
8 F CDMS 0101  1101 0202 0301  0501
9 F ADEM 0101  1501 0101 0501  0602
10 M CIS 1302  1405 0202  0301 0609  0503
11 M ADEM 0901  1504 0101? 0101? 0303  0601
12 F TM 0301  1001 0106 0201  0501
13 M ADEM 1302  1501 0301 0101 0602  0604
Table 2. HLA-DRB and DQB alleles in subjects (n=13)
Male (M)/Female (F).
ANEBG, acute necrotizing encephalitis with basal ganglia involvement; AEBTT, acute encephalopathy with bilateral thalamotegmental involvement;
CDMS/CIS, clinically definite multiple sclerosis or clinically isolated syndromes suggestive of MS; TM, transverse myelitis; ADEM, acute disseminated
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indicative of ADEM (5, 17). It will be very interesting if we
were able to clarify whether these conditions have their own
specific biological markers or share the markers. We sought
to assess a possible relationship between HLA class II genes
and neuroinflammatory diseases such as MS and ADEM. This
is the pilot study to evaluate the immunogenetic background
of neuroinflammatory diseases in Asian children.
We analyzed HLA determinants in thirteen Korean chil-
dren consecutively diagnosed with neuroinflammatory dis-
ease. As illustrated in Table 1, ADEM is still the major con-
dition despite the fact that a lot of children with ADEM were
not enrolled for many reasons. We had two cases of clinical-
ly definite multiple sclerosis (CDMS) who met the diagnos-
tic criteria (18-20). In addition, there was a child with Clini-
cally Isolated Syndromes (CIS) suggestive of MS. Few pedi-
atric cases of CDMS have been reported in Korea. However,
recently the number is increasing. This is probably due to rapid
westernization of the country, availability of clinically qualified
experts, and improvement of diagnostic tools. A few cases of
ANEBTT were also included in the study. 
The subjects were genotyped using PCR-SSOP/SSP tech-
niques for HLA DRB/HLA DQB genes with augmentation
and gel immunoelectrophoresis. As shown in Table 2, the fre-
quencies of HLA-DR1*15 and DQB1*06 were significantly
increased in neuroinflammatory diseases compared with con-
trol subjects as well as known data of HLA-DRB alleles in
Korean (21, 22). The results are similar to previous reports
from Western countries and partly supports our hypothesis
(23). The five most common alleles in these children were
DRB3*0202 (46%), DRB1*0101 (23%), DRB1*1302
(23%), DQB1*0301 (23%), and DQB1*0501 (23%). Like
previous Japanese studies (24, 25), the frequencies of HLA-
DRB1*1501, HLA-DRB5*0101, HLA-DRB3*0301, and
HLA-DQB1*0602 were not as high in Korean children with
MS as in western children (1-3, 26-29). A very strong corre-
lation of the condition with HLA-DRB3*0202, HLA-DRB1*
1302, HLA-DRB3*0301, and HLA-DQB1* 0301 alleles
was verified instead (Table 3). These findings may provide
the evidence for correlation of these alleles and susceptibility
of Korean children to MS. The frequencies of HLA-DRB1*
1501 (40%) and HLA-DRB5*0101 (40%) were significantly
increased in children with ADEM compared with control
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Fig. 1. Molecular analysis of HLA-DRB/HLA-DQB
genes in a case of ADEM with the western genotype
of multiple sclerosis. PCR-SSOP (A), PCR-SSP (B) with
gel Immunoelectrophoresis for HLA-DQB (C) illustrates
HLA-DRB1*1501 and HLA-D QB1*0602/0604.
DRB1 DRB3 DQB1
A 0701 1401 0202 0303 0502 
B 1101 1401 0202 0301 0502
C 0101 1302 0301 0501 0609
Table 4. HLA-DRB and DQB alleles of patients with ANEBTT
AEBTT, acute encephalopathy with bilateral thalamotegmental involve-
ment.
Korean Western
DRB3*0202 (100%) DRB1*1501
DRB1*1302 (67%) DRB5*0101
DRB3*0301 (67%) DRB3*0301
DQB1*0301 (67%) DQB1*0602
Table 3. Frequent alleles of HLA-DRB and DQB in patients with
multiple sclerosisHLA Susceptibility to Neuroinflammatory Diseases in Korean Children 429
subjects. Interestingly, there was one child with a clinically
strong feature of ADEM, but he had the western genotype of
MS, HLA-DRB1*1501 and HLA-DQB1*0602 (Fig. 1). He
is still visiting the clinic and has not had any relapse yet. Al-
though the same HLA determinants were found in this pa-
tient as in those with MS, further studies on a larger number
of patients with postinfectious encephalomyelitis are needed
before we can conclude with certainty that the two diseases
share a common genetic propensity. Finally, it is noteworthy
that three common alleles, HLA-DRB1*1401, HLA-DRB3*
0202, and HLA-DQB1*0502 were found in children with
ANEBTT (Table 4). With our limited knowledge, ANEBTT
is not a common illness worldwide and has never been molec-
ularly evaluated, so this result might be valuable. However,
further studies are required to elucidate the condition.
In conclusion, HLA-DR1*15 and DQB1*06 may be in-
volved in susceptibility to inflammation in Korean children.
The frequencies of HLA-DRB1*1501, HLA-DRB5*0101,
HLA-DRB3*0301, and HLA-DQB1*0602 were not as high
in Korean children with MS as in western children. HLA-
DRB3*0202 was seen in all children with MS. Our data may
provide further evidence that the immunogenetic background
of neuroinflammatory diseases in Asians is distinctly different
from that in western countries. Further studies are necessary
to confirm this finding. 
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